Sand Study Circle: May 2026

Less...

Learning Objectives

  • Describe key concepts presented in the article related to miniature-free sand work in school-based settings.
  • Identify potential therapeutic benefits of miniature-free sand work, including sensory, symbolic, relational, and regulatory dimensions.
  • Reflect on how the article’s ideas may inform clinical, school-based, or sand therapy practice with children and adolescents.

Target Audience

This educational activity is intended for behavioral health professionals, including Psychologists, Social Workers, Counselors, and MFT's.

Learning Levels

  • Beginner / Intermediate

Monday, May 25, 2026

Live Interactive Webinar

12:00 PM EDT - 01:30 PM EDT

EARN 1.5 CE Credit Hours

About the speakers

Agenda

Agenda

0:00–0:10 | Welcome and Introductions
Brief welcome, overview of the study circle, and opening reflection.

0:10–0:25 | Article Overview
General discussion of key themes and concepts from the reading.

0:25–0:45 | Group Discussion: Main Takeaways
Participants share what stood out to them from the article.

0:45–1:05 | Group Discussion: Practice Connections
Participants reflect on possible connections to clinical, school-based, or sand therapy practice.

1:05–1:20 | Group Reflection
Open discussion around questions, insights, and areas for continued exploration.

1:20–1:30 | Closing
Final takeaways, CE reminders, and closing comments.

CE Information - Earn 1.5 CE Credit Hours including

 Trusting the Process Hour

CE Approvals

National Board of Professional Counselors
World Association of Sand Therapy Professionals approved provider ACEP No. 7497.

CE Process Info

Before the event, you will receive an email from CE-Go with access to the virtual event. After the event, you will receive access to your evaluation and continuing education certificate via a personalized "attendee dashboard" link, hosted on the CE-Go website. This link and access to the virtual event will be sent to the email account you used to register for the event.

Upon accessing the CE-Go "attendee dashboard", you will be able to:

  • Complete evaluation forms for the event
  • Download your continuing education certificate in a PDF format

If you have any questions or concerns regarding the CE-Go platform, please contact CE-Go at 888-498-5578 or by email at support@ce-go.com Please Note: Emails for this event will come from "support@ceactivities.com".

If you have any continuing education related questions, please contact your event organizer.

Please make sure to check your spam/junk folder in case those emails get "stuck". We'd also suggest "Allowlisting" support@ceactivities.com. This tells your email client that you know this sender and trust them, which will keep emails from this contact at the top of your inbox and out of the junk folder.

Disclosure

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
CE Learning Systems adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity ― including faculty, planners, reviewers, or others ― are required to disclose all relevant financial relationships with ineligible entities (formerly known as commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

The following relevant financial relationships have been disclosed by this activity’s planners, faculty, and the reviewer:


PLANNERS AND REVIEWER
The planners of this activity have reported that they have no relevant financial relationships.

FACULTY
Dr. <>, the faculty for this activity, reports the following relevant financial relationships:

Consultant - AbbVie, ANeuroTech (division of Anima BV), Signant Health, Magstim, Inc., Intra-Cellular Therapies, Inc., EMA Wellness, Sage, Silo Pharma, Engrail Therapeutics, Pasithea Therapeutic Corp., GoodCap Pharmaceuticals, Inc., Senseye, Clexio, Ninnion Therapeutics, EmbarkNeuro, SynapseBio, BioXcel Therapeutics, Relmada Therapeutics

Ownership Interest - Seattle Genetics, Antares, Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness, Naki Health, Relmada Therapeutics
Advisor - ANeuroTech (division of Anima BV), Brain and Behavior Research Foundation (BBRF), Anxiety and Depression Association of America (ADAA), Skyland Trail, Signant Health, Laureate Institute for Brain Research (LIBR), Inc., Heading Health, Pasithea Therapeutic Corp., Sage

Executive Role - Gratitude America, ADAA, Lucy Scientific Discovery, Inc.

Royalty Or Patent Beneficiary - Method and devices for transdermal delivery of lithium (US 6,375,990B1) Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2)